Filing Details

Accession Number:
0001562180-22-007177
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-10-12 18:50:15
Reporting Period:
2022-10-07
Accepted Time:
2022-10-12 18:50:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1404123 1Life Healthcare Inc ONEM Services-Offices & Clinics Of Doctors Of Medicine (8011) 760707204
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1642829 Dan Amir Rubin C/O 1Life Healthcare, Inc.
One Embarcadero Center, Suite 1900
San Francisco CA 94111
Chair, Ceo And President No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-10-07 1,128,882 $4.01 1,228,630 No 4 M Direct
Common Stock Acquisiton 2022-10-07 242,235 $11.56 1,470,865 No 4 M Direct
Common Stock Disposition 2022-10-07 1,371,117 $17.03 99,748 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to buy) Disposition 2022-10-07 1,128,882 $0.00 1,128,882 $4.01
Common Stock Stock Option (Right to Buy) Disposition 2022-10-07 242,235 $0.00 242,235 $11.56
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2027-09-13 No 4 M Direct
2,064,765 2029-11-20 No 4 M Direct
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan and were conducted by the reporting person for tax and estate planning purposes. The reporting person has adopted Rule 10b5-1 plans in the past and has adopted this Rule 10b5-1 plan in the ordinary course. The trading plans and their parameters do not reflect the reporting person's views on the closing of the pending, previously announced, merger or the prospects of the Company's business after the closing.
  2. This transaction was executed in multiple trades at prices ranging from $16.95 to $17.085. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. The shares subject to the option vested as follows: 20% of the shares subject to the option vested on the first anniversary of the vesting commencement date; and 1/60th of the shares subject to the option vested monthly thereafter over the following four years, subject to the reporting person's continuous service as of each such date.
  4. The shares subject to the option vest as follows: 63% of the shares subject to the option vest ratably on a monthly basis from the vesting commencement date through August 2023; 25% of the shares subject to the option vest ratably on a monthly basis from September 2023 to August 2024; and the remaining 12% of the shares subject to the option vest ratably on a monthly basis from September 2024 to August 2025, subject to the reporting person's continuous service as of each such date.